Harris Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-118,776
Closed -$7.52M 138
2017
Q3
$7.52M Buy
118,776
+8,676
+8% +$539K 0.01% 112
2017
Q2
$7.03M Buy
+110,100
New +$6.92M 0.01% 108
2015
Q2
Sell
-4,435
Closed -$385K 163
2015
Q1
$385K Buy
4,435
+1,400
+46% +$117K ﹤0.01% 154
2014
Q4
$257K Sell
3,035
-2,889
-49% -$226K ﹤0.01% 175
2014
Q3
$418K Hold
5,924
﹤0.01% 157
2014
Q2
$411K Hold
5,924
﹤0.01% 161
2014
Q1
$445K Sell
5,924
-71
-1% -$5.32K ﹤0.01% 159
2013
Q4
$421K Hold
5,995
﹤0.01% 164
2013
Q3
$370K Buy
5,995
+33
+0.6% +$2.13K ﹤0.01% 165
2013
Q2
$368K Buy
+5,962
New +$359K ﹤0.01% 173

Other funds holding ESRX

Harris Associates's ESRX Position: Q4 2017 in Review

Harris Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2017, closing a stake of 118,776 shares — an estimated $7.52M sold.

Harris Associates first reported a position in ESRX in Q2 2013 and held it in 10 quarters. The position peaked at $7.52M in Q3 2017. 1,109 funds tracked by Wall St. Rank hold ESRX as of Q4 2017.

  • Harris Associates reported no remaining Express Scripts Holding Company position as of Q4 2017 after selling out during the quarter.
  • Harris Associates sold 118,776 Express Scripts Holding Company shares in Q4 2017, an estimated $7.52M.
  • Harris Associates first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 10 quarters.
  • Harris Associates's Express Scripts Holding Company position peaked at $7.52M in Q3 2017.
  • 1,109 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2017.

Based on Harris Associates's 13F filing for Q4 2017, filed 14 Feb 2018.